Paula Suzanne Stephens, APRN | |
2708 S Rife Medical Ln Ste 140, Rogers, AR 72758 | |
(479) 338-3720 | |
(479) 338-3749 |
Full Name | Paula Suzanne Stephens |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 5 Years |
Location | 2708 S Rife Medical Ln Ste 140, Rogers, Arkansas |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1326690132 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | 121401 (Arkansas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Mercy Hospital Northwest Arkansas | Rogers, AR | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mercy Health Northwest Arkansas Communities | 0648177873 | 265 |
News Archive
James McGillicuddy was not getting good news. Three years after arriving at Stanford as one of the nation's top high school football recruits, he'd been stuck on the sidelines the entire time by a torn tendon that, even with two surgeries, just wouldn't stay fixed. More surgery would not help, his doctors told him, but they did have one last option to offer him.
Agricultural workers exposed to high levels of pesticides and people who use them on houseplants appear to have a greater risk of developing brain tumours, suggests a study published online ahead of print in Occupational and Environmental Medicine.
The Health Law Practice of Mintz Levin Cohn Ferris Glovsky and Popeo, P.C. is a sponsor of the Women Business Leaders of the U.S. Health Care Industry Foundation and WBL's 10th Annual Summit.
Biologics, Inc., an oncology management company, has been recognized by the National Comprehensive Cancer Network® (NCCN®) for its commitment to supporting patient access to quality oncology care. For the first time, the NCCN, a not-for-profit alliance of 21 of the world's leading cancer centers, is recognizing commercial payor and non-payor organizations, including Biologics, which support the appropriate, effective, and efficient use of oncology treatment and care of patients through its new NCCN Recognition Program.
Using just two anticlotting medicines for patients who have atrial fibrillation and have had a stent placed in a heart artery is safer than using the current standard treatment of three medications, according to a new study presented by Brigham and Women's Hospital cardiologist Christopher Cannon, MD, at the European Society of Cardiology and published simultaneously in The New England Journal of Medicine.
› Verified 5 days ago
Entity Name | Mercy Health Northwest Arkansas Communities |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1265490916 PECOS PAC ID: 0648177873 Enrollment ID: O20031216000788 |
News Archive
James McGillicuddy was not getting good news. Three years after arriving at Stanford as one of the nation's top high school football recruits, he'd been stuck on the sidelines the entire time by a torn tendon that, even with two surgeries, just wouldn't stay fixed. More surgery would not help, his doctors told him, but they did have one last option to offer him.
Agricultural workers exposed to high levels of pesticides and people who use them on houseplants appear to have a greater risk of developing brain tumours, suggests a study published online ahead of print in Occupational and Environmental Medicine.
The Health Law Practice of Mintz Levin Cohn Ferris Glovsky and Popeo, P.C. is a sponsor of the Women Business Leaders of the U.S. Health Care Industry Foundation and WBL's 10th Annual Summit.
Biologics, Inc., an oncology management company, has been recognized by the National Comprehensive Cancer Network® (NCCN®) for its commitment to supporting patient access to quality oncology care. For the first time, the NCCN, a not-for-profit alliance of 21 of the world's leading cancer centers, is recognizing commercial payor and non-payor organizations, including Biologics, which support the appropriate, effective, and efficient use of oncology treatment and care of patients through its new NCCN Recognition Program.
Using just two anticlotting medicines for patients who have atrial fibrillation and have had a stent placed in a heart artery is safer than using the current standard treatment of three medications, according to a new study presented by Brigham and Women's Hospital cardiologist Christopher Cannon, MD, at the European Society of Cardiology and published simultaneously in The New England Journal of Medicine.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Paula Suzanne Stephens, APRN 2708 S Rife Medical Ln Ste 140, Rogers, AR 72758-1455 Ph: (479) 338-3720 | Paula Suzanne Stephens, APRN 2708 S Rife Medical Ln Ste 140, Rogers, AR 72758 Ph: (479) 338-3720 |
News Archive
James McGillicuddy was not getting good news. Three years after arriving at Stanford as one of the nation's top high school football recruits, he'd been stuck on the sidelines the entire time by a torn tendon that, even with two surgeries, just wouldn't stay fixed. More surgery would not help, his doctors told him, but they did have one last option to offer him.
Agricultural workers exposed to high levels of pesticides and people who use them on houseplants appear to have a greater risk of developing brain tumours, suggests a study published online ahead of print in Occupational and Environmental Medicine.
The Health Law Practice of Mintz Levin Cohn Ferris Glovsky and Popeo, P.C. is a sponsor of the Women Business Leaders of the U.S. Health Care Industry Foundation and WBL's 10th Annual Summit.
Biologics, Inc., an oncology management company, has been recognized by the National Comprehensive Cancer Network® (NCCN®) for its commitment to supporting patient access to quality oncology care. For the first time, the NCCN, a not-for-profit alliance of 21 of the world's leading cancer centers, is recognizing commercial payor and non-payor organizations, including Biologics, which support the appropriate, effective, and efficient use of oncology treatment and care of patients through its new NCCN Recognition Program.
Using just two anticlotting medicines for patients who have atrial fibrillation and have had a stent placed in a heart artery is safer than using the current standard treatment of three medications, according to a new study presented by Brigham and Women's Hospital cardiologist Christopher Cannon, MD, at the European Society of Cardiology and published simultaneously in The New England Journal of Medicine.
› Verified 5 days ago